SAN JOSE – – November 03, 2026 -- Cisco (NASDAQ: CSCO) will report first-quarter fiscal 2027 results on Thursday, Nov. 12, 2026, after the market close, covering the period ended Saturday, Oct. 24, 2026.

Cisco schedules a 1:30 PM PT management call for Nov. 12

The conference call begins at 1:30 PM Pacific (4:30 PM Eastern). The company will distribute the earnings release via PR Newswire through its US National and European Financial services. It will also post the release on its newsroom site.

HOUSTON – November 03, 2026 -- Bristow Group Inc. (NYSE: VTOL) reported third-quarter 2026 net income of $27.7 million, or $0.93 per diluted share, up from $21.2 million, or $0.70 per share, in the preceding quarter. Total revenues rose to $437.9 million from $411.8 million, and Adjusted EBITDA increased to $89.6 million from $79.8 million. The company affirmed the midpoint of its 2026 Adjusted EBITDA guidance.

Paris – November 03, 2026 -- Stingray demonstrated its Stingray Karaoke app inside the BYD Atto 3 at the Mondial de l'Auto, extending a partnership with the Chinese automaker that began with the product's first vehicle launch in 2022.

The show was dominated by Chinese and German manufacturers, and Stingray says in-cabin user experience has become a new battleground for consumer loyalty.

Rostock – – November 03, 2026 -- The German Navy Command has published its annual report "Maritime Dependencies of Germany" for 2025, warning that attacks on the Strait of Hormuz hit Germany "hard and directly" despite a 6,500-nautical-mile distance to the Port of Hamburg.

The Naval Shipping Management in Hamburg compiled the report. It bundles analysis and data on maritime security, seaborne trade, German seaports, global shipbuilding and the merchant fleet.

Laval – November 03, 2026 -- Spektus Pharma and GEBRO Holding have agreed a global commercialization partnership for ActraFlex, a twice-daily extended-release tramadol/paracetamol formulation for pain management.

GEBRO takes Europe and Spektus takes the Americas under a split-territory deal

GEBRO, headquartered in Fieberbrunn, Austria, will lead commercialization and supply across Europe and selected international markets. The rollout is anchored by Spain, where GEBRO's Diliban brand has an established commercial presence.

Rome – – November 03, 2026 --

The START Center for Cancer Research will open its first Italian early-phase oncology trial site inside Rome's IRCCS Istituto Nazionale Tumori Regina Elena, under a strategic partnership with the public hospital organization Istituti Fisioterapici Ospitalieri (IFO). The site will be fully integrated into START's network and will have access to its global trial portfolio from day one.

Copenhagen – November 03, 2026 -- Cambiotics ApS has enrolled the first participant in its first human clinical trial, testing whether its probiotic strain 46-SL1 changes serum PFAS concentrations in 70 firefighters with prior occupational exposure.

Slovakia – November 03, 2026 -- The EU Agency for the Cooperation of Energy Regulators (ACER) has found that Eustream's proposed gas transmission tariffs, which would raise charges by more than 50% midway through the current tariff period, do not comply with the EU Network Code on Harmonised Transmission Tariff Structures (NC TAR).

Burlington – November 03, 2026 -- PAQ Therapeutics will present the first clinical data for PT0253, its selective KRAS G12D degrader, in a late-breaking oral session at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026) in Barcelona, Spain, on November 20.

Dusseldorf – November 03, 2026 -- More than 500 start-ups will exhibit among several thousand exhibitors at MEDICA 2026, held 16-19 November in Düsseldorf, and the 15th MEDICA START-UP COMPETITION will stage its pitch final on the new MEDICA MAIN STAGE in Hall 12 for the first time.